BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 24096022)

  • 1. In Vitro and In Silico Characterization of an Antimalarial Compound with Antitumor Activity Targeting Human DNA Topoisomerase IB.
    Soren BC; Babu Dasari J; Ottaviani A; Messina B; Andreotti G; Romeo A; Iacovelli F; Falconi M; Desideri A; Fiorani P
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of recombinant Pneumocystis carinii topoisomerase I: differential interactions with human topoisomerase I poisons and pentamidine.
    van Dross RT; Sanders MM
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2145-54. PubMed ID: 12069967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition.
    Pommier Y
    Chem Rev; 2009 Jul; 109(7):2894-902. PubMed ID: 19476377
    [No Abstract]   [Full Text] [Related]  

  • 4. Covalent Complex of DNA and Bacterial Topoisomerase: Implications in Antibacterial Drug Development.
    Tiwari PB; Chapagain PP; Seddek A; Annamalai T; Üren A; Tse-Dinh YC
    ChemMedChem; 2020 Apr; 15(7):623-631. PubMed ID: 32043806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of functional protein domains by unbiased genome-wide forward genetic screening.
    Herzog M; Puddu F; Coates J; Geisler N; Forment JV; Jackson SP
    Sci Rep; 2018 Apr; 8(1):6161. PubMed ID: 29670134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topoisomerase IB: a relaxing enzyme for stressed DNA.
    Soren BC; Dasari JB; Ottaviani A; Iacovelli F; Fiorani P
    Cancer Drug Resist; 2020; 3(1):18-25. PubMed ID: 35582040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulations of DNA topoisomerase 1B bound to supercoiled DNA reveal changes in the flexibility pattern of the enzyme and a secondary protein-DNA binding site.
    D'Annessa I; Coletta A; Sutthibutpong T; Mitchell J; Chillemi G; Harris S; Desideri A
    Nucleic Acids Res; 2014 Aug; 42(14):9304-12. PubMed ID: 25056319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based analysis of the effects of camptothecin on the activities of human topoisomerase I.
    Champoux JJ
    Ann N Y Acad Sci; 2000; 922():56-64. PubMed ID: 11193925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of DNA topoisomerase I-induced cell killing in the yeast Saccharomyces cerevisiae.
    Fiorani P; Bjornsti MA
    Ann N Y Acad Sci; 2000; 922():65-75. PubMed ID: 11193926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human topoisomerase 1B Arg634Ala mutation results in camptothecin resistance and loss of inter-domain motion correlation.
    D'Annessa I; Tesauro C; Wang Z; Arnò B; Zuccaro L; Fiorani P; Desideri A
    Biochim Biophys Acta; 2013 Dec; 1834(12):2712-21. PubMed ID: 24096022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of Gly717Phe in human topoisomerase 1B has an effect on enzymatic function, reactivity to the camptothecin anticancer drug and on the linker domain orientation.
    Wang Z; D'Annessa I; Tesauro C; Croce S; Ottaviani A; Fiorani P; Desideri A
    Biochim Biophys Acta; 2015 Aug; 1854(8):860-8. PubMed ID: 25910424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanism of the camptothecin resistance of Glu710Gly topoisomerase IB mutant analyzed in vitro and in silico.
    Tesauro C; Morozzo della Rocca B; Ottaviani A; Coletta A; Zuccaro L; Arnò B; D'Annessa I; Fiorani P; Desideri A
    Mol Cancer; 2013 Sep; 12(1):100. PubMed ID: 24004603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insight of DNA topoisomerases I from camptothecin-producing plants revealed by molecular dynamics simulations.
    Sirikantaramas S; Meeprasert A; Rungrotmongkol T; Fuji H; Hoshino T; Sudo H; Yamazaki M; Saito K
    Phytochemistry; 2015 May; 113():50-6. PubMed ID: 25733498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin.
    Wright CM; van der Merwe M; DeBrot AH; Bjornsti MA
    J Biol Chem; 2015 May; 290(19):12068-78. PubMed ID: 25795777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single mutation in the linker domain confers protein flexibility and camptothecin resistance to human topoisomerase I.
    Fiorani P; Bruselles A; Falconi M; Chillemi G; Desideri A; Benedetti P
    J Biol Chem; 2003 Oct; 278(44):43268-75. PubMed ID: 12904303
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.